Featured Research

from universities, journals, and other organizations

Testosterone Levels Early In Life May Determine Later Risk Of Prostate Cancer

Date:
October 16, 1997
Source:
Duke University Medical Center
Summary:
Duke University Medical Center researchers have found preliminary evidence suggesting a man's lifetime risk of prostate cancer may be linked to the amount of male hormone testosterone circulating in his body as early as puberty or even in utero, although direct evidence of this link remains to be shown.

DURHAM, N.C. -- Duke University Medical Center researchers have foundpreliminary evidence suggesting a man's lifetime risk of prostate cancer may belinked to the amount of male hormone testosterone circulating in his body asearly as puberty or even in utero, although direct evidence of this link remainsto be shown.

Related Articles


The two possible risk factors they found -- high "free" testosteronelevels in adulthood and a small shoulder span in relation to body size -- appearto be unrelated to one another. However, they are both tied to hormone levels atvarious stages of development, said Wendy Demark-Wahnefried, associate professorof surgery at Duke and lead author of two parts of a study that produced thefindings.

While doctors won't be able to predict who will get the disease based onthese two factors alone, the results suggest that "free" hormone levels andshoulder span could be benchmarks for determining who is at greater risk for thedisease, Demark-Wahnefried said. Free testosterone refers to a type of hormonethat is not bound to a protein and thus can freely enter cells throughout thebody.

"We have to look at how hormone levels at different points in timeactually determine the risk of prostate cancer," she said. "It is hypothesizedthat hormone levels throughout life -- ranging from in utero to old age -- drivesuch events as skeletal and muscle formation, fat deposition, baldness, and thatthese events may provide the initial stimuli and promotion for prostate cancer.

"By studying the tell-tale signs that hormones leave on the body, ourgoal was to clearly separate those men at risk for prostate cancer from thosewho are not."

Demark-Wahnefried's research, funded by the National Cancer Instituteand the Cancer Research Foundation of America, set out to measure the linkbetween prostate cancer and factors such as height, weight, musculature andbaldness -- all of which are related to hormones. The two-year, blinded,case-controlled study compared a group of 159 men with prostate cancer to acontrol group of 156 men who had come to the urology clinic for prostatescreenings and other concerns such as kidney stones. Subjects were aged 50 to70 years.

In the first phase of the study, Demark-Wahnefried and her colleagues atthe Duke Comprehensive Cancer Center found nearly a two-fold increase in therisk of prostate cancer among men with high "free" testosterone levels, the formof testosterone that can readily be used by cells throughout the body.

While the link between testosterone and prostate cancer has been madebefore, previous studies have measured "total" testosterone, a less active formof the hormone that is bound to specific protein and thus cannot enter thecells.

The researchers also found a link between high testosterone levels andvertex or "top of head" baldness. However, baldness was not linked to prostatecancer in the study subjects, probably because baldness is as much related toage as it is to other factors like testosterone, she said.

Demark-Wahnefried theorizes that baldness at a younger age, perhaps at40, could be used to predict the later risk of prostate cancer, a theory thatshe plans to study next.

The part of the study that looked at baldness, testosterone levels andprostate cancer is published in the September/October issue of the Journal ofAndrology. Co-authors of that study include Samuel M. Leski of Boston UniversitySchool of Medicine and Mark R. Conaway, Cary N. Robertson, Richard V. Clark,Bruce Lobaugh, Barbara J. Mathias, Tara Smith Strigo, and David F. Paulson ofDuke.

In the next phase of the study, published in the September issue of theJournal of Nutrition and Cancer, researchers found that men with prostatecancer were more likely to have a narrower shoulder span in proportion to theiroverall body size, a trait that earlier studies have shown to be determinedduring puberty.

Demark-Wahnefried said those earlier studies, although quite limited intheir sample size, showed that men who go through puberty later have a broadershoulder span than men who go through puberty early. She said this findingsuggests that hormone levels have a direct influence on shoulder span.

While the difference in shoulder span was less than a centimeter,Demark-Wahnefried said it was the only physical factor she studied that wassignificantly associated with prostate cancer.

"Shoulder span may provide us with a benchmark of past hormonal and/ornutritional status and help elucidate the etiology of this disease," she said.

While researchers have long believed that prostate cancer is linked tomale hormone levels, Demark-Wahnefried said the existing research has yieldedconflicting results, similar to the controversy surrounding estrogen as a riskfactor for breast cancer.

The current studies provide strong evidence that risk of prostate canceris, in fact, influenced by hormonal events that occur much earlier in life, suchas the formation of skeletal frame, she said. However, Demark-Wahnefried saidthese events may originate in utero and continue to manifest themselves atdevelopmental milestones throughout a man's life.

In her next phase of research, Demark-Wahnefried and colleagues JoellenSchildkraut and Philip Walhter will study the link between baldness and prostatecancer in younger men as well as hormonal differences between younger men, aged18 to 35, who have a strong family history of prostate cancer versus those fromfamilies with no history of the disease.


Story Source:

The above story is based on materials provided by Duke University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Duke University Medical Center. "Testosterone Levels Early In Life May Determine Later Risk Of Prostate Cancer." ScienceDaily. ScienceDaily, 16 October 1997. <www.sciencedaily.com/releases/1997/10/971013061355.htm>.
Duke University Medical Center. (1997, October 16). Testosterone Levels Early In Life May Determine Later Risk Of Prostate Cancer. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/1997/10/971013061355.htm
Duke University Medical Center. "Testosterone Levels Early In Life May Determine Later Risk Of Prostate Cancer." ScienceDaily. www.sciencedaily.com/releases/1997/10/971013061355.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Christmas Kissing Good for Health

Christmas Kissing Good for Health

Reuters - Innovations Video Online (Dec. 22, 2014) Scientists in Amsterdam say couples transfer tens of millions of microbes when they kiss, encouraging healthy exposure to bacteria. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Brain-Dwelling Tapeworm Reveals Genetic Secrets

Brain-Dwelling Tapeworm Reveals Genetic Secrets

Reuters - Innovations Video Online (Dec. 22, 2014) Cambridge scientists have unravelled the genetic code of a rare tapeworm that lived inside a patient's brain for at least four year. Researchers hope it will present new opportunities to diagnose and treat this invasive parasite. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins